Related Experiment Video
Updated: Jun 11, 2025

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
Whitaker syndrome: A case report of autoimmune polyendocrine syndrome type 1 with dilated cardiomyopathy
Ali Gohar1, Bilal Ahmed1, Shahroz Azhar2
1Lahore General Hospital Lahore Punjab Pakistan.
Insights
This case report details a rare presentation of Autoimmune Polyendocrine Syndrome type 1 (APS-1) with dilated cardiomyopathy. Early diagnosis and multidisciplinary care are vital for managing this cardiovascular complication.
Area of Science:
- Endocrinology
- Cardiology
- Genetics
Background:
- Autoimmune Polyendocrine Syndrome type 1 (APS-1), or Whitaker syndrome, is a rare autosomal recessive disorder.
- It is caused by mutations in the autoimmune regulator (AIRE) gene.
- Cardiovascular and pulmonary manifestations are infrequently reported in APS-1.
Purpose of the Study:
- To highlight dilated cardiomyopathy as a potential cardiovascular complication of APS-1.
- To emphasize the importance of early recognition and multidisciplinary management for atypical APS-1 presentations.
Main Methods:
- Case report of a 28-year-old male with shortness of breath and pedal edema.
- Diagnostic workup included physical examination, echocardiography, chest x-ray, and laboratory investigations (hormone levels, electrolytes).
- Diagnosis of APS-1 was confirmed by the presence of chronic mucocutaneous candidiasis, hypoparathyroidism, and adrenal insufficiency.
Main Results:
- The patient presented with clinical features of APS-1 and was diagnosed with dilated cardiomyopathy (DCM) and pericardial effusion.
- Echocardiography revealed DCM and pericardial effusion; chest x-ray showed left-sided pleural effusion.
- Laboratory findings included hypocalcemia, hyperphosphatemia, low PTH, low cortisol, and high ACTH levels.
Conclusions:
- Dilated cardiomyopathy is a significant cardiovascular complication of APS-1.
- Early recognition and a multidisciplinary approach are crucial for optimizing patient outcomes in APS-1.
- This is the first reported case from Pakistan and second globally of APS-1 with this specific combination of manifestations.
Key Clinical Message:
This case report highlights dilated cardiomyopathy as a cardiovascular complication in autoimmune polyendocrine syndrome type 1 (APS-1), emphasizing the need for early recognition and a multidisciplinary approach. Comprehensive care and regular follow-up are crucial in managing these atypical presentations to optimize patient outcomes.
Abstract:
APS-1, also known as Whitaker syndrome, is characterized by a triad of mucocutaneous candidiasis, adrenal insufficiency, and hypoparathyroidism. This rare autosomal recessive disorder results from mutations in the autoimmune regulator (AIRE) gene. Cardiovascular and pulmonary manifestations in APS-1 are infrequently reported in the literature. We present a case of a 28-year-old male who presented with shortness of breath and pedal edema. Physical examination revealed alopecia, absence of eyebrows, hyperpigmentation on joints, oral candidiasis, and nail dystrophy. Echocardiography demonstrated dilated cardiomyopathy (DCM) and pericardial effusion. Chest x-ray showed left-sided pleural effusion. Laboratory investigations revealed hypocalcemia, hyperphosphatemia, low parathyroid hormone (PTH), low cortisol, and high adrenocorticotropic hormone (ACTH) levels. The combination of chronic mucocutaneous candidiasis (CMC), hypoparathyroidism, and adrenal insufficiency confirmed the diagnosis of APS-1. To the best of our knowledge, this is the first Pakistani and second worldwide reported case of APS-1 presenting with such a combination of manifestations. Early recognition and multidisciplinary management are crucial for improving outcomes in these patients.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Myocarditis II: Clinical features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care